Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18180353rdf:typepubmed:Citationlld:pubmed
pubmed-article:18180353lifeskim:mentionsumls-concept:C1265292lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C1136254lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C1506687lld:lifeskim
pubmed-article:18180353lifeskim:mentionsumls-concept:C2001521lld:lifeskim
pubmed-article:18180353pubmed:issue3lld:pubmed
pubmed-article:18180353pubmed:dateCreated2008-2-26lld:pubmed
pubmed-article:18180353pubmed:abstractTextTwo investigational anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) beta-lactams, ceftaroline (a cephalosporin) and ME1036 (a carbapenem), were subjected to susceptibility testing by reference broth microdilution methods using 152 strains of community-acquired MRSA from the United States (47 medical centers). Ceftaroline and ME1036 were 64- and >128-fold more potent than ceftriaxone, respectively. All isolates had the Panton-Valentine leukocidin genes and staphylococcal cassette chromosome mec type IV, while 67.8% of isolates displayed pulsed-field gel electrophoresis clonal type USA300-0114.lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:languageenglld:pubmed
pubmed-article:18180353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:citationSubsetIMlld:pubmed
pubmed-article:18180353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18180353pubmed:statusMEDLINElld:pubmed
pubmed-article:18180353pubmed:monthMarlld:pubmed
pubmed-article:18180353pubmed:issn0066-4804lld:pubmed
pubmed-article:18180353pubmed:authorpubmed-author:JonesRonald...lld:pubmed
pubmed-article:18180353pubmed:authorpubmed-author:SaderHelio...lld:pubmed
pubmed-article:18180353pubmed:authorpubmed-author:FritscheThoma...lld:pubmed
pubmed-article:18180353pubmed:issnTypePrintlld:pubmed
pubmed-article:18180353pubmed:volume52lld:pubmed
pubmed-article:18180353pubmed:ownerNLMlld:pubmed
pubmed-article:18180353pubmed:authorsCompleteYlld:pubmed
pubmed-article:18180353pubmed:pagination1153-5lld:pubmed
pubmed-article:18180353pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:meshHeadingpubmed-meshheading:18180353...lld:pubmed
pubmed-article:18180353pubmed:year2008lld:pubmed
pubmed-article:18180353pubmed:articleTitleAntimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.lld:pubmed
pubmed-article:18180353pubmed:affiliationJMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA. helio-sader@jmilabs.comlld:pubmed
pubmed-article:18180353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18180353pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18180353lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18180353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18180353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18180353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18180353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18180353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18180353lld:pubmed